1-3 of 3
Eugenio Torre
Close
Sort by
Journal Articles

Treatment with hERG1 K + Channel Inhibitors Reduces Acute Myeloid Leukemia Cell Lines Engraftment into Nonobese Diabetic/Severe Combined Immunodeficient Mice and Prolongs Survival of Injected Mice.

Serena Pillozzi, Emanuele De Lorenzo, Marika Masselli, Olivia Crociani, Emanuele Cilia, Eugenio Torre, Antonio Mugnai, Andrea Becchetti, Annarosa Arcangeli
Journal: Blood
Blood (2007) 110 (11): 877.
https://doi.org/10.1182/blood.V110.11.877.877
Published: 2007
Journal Articles

VEGFR-1 (FLT-1), b 1 Integrin and hERG K + Channel Form a Macromolecular Signaling Complex in Acute Myeloid Leukemia Cells.

Annarosa Arcangeli, Serena Pillozzi, PhD, student, Maria F. Brizzi, Researcher, Pietro A. Bernabei, clinician, Benedetta Bartolozzi, clinician, Roberto Caporale, biologist, Venere Basile, fellow, Vieri Boddi, Eugenio Torre, technician, Luigi Pegoraro, Andrea Becchetti
Journal: Blood
Blood (2006) 108 (11): 2366.
https://doi.org/10.1182/blood.V108.11.2366.2366
Published: 2006
Journal Articles

A pathobiologic pathway linking thrombopoietin, GATA-1, and TGF-β1 in the development of myelofibrosis

Alessandro M. Vannucchi, Lucia Bianchi, Francesco Paoletti, Alessandro Pancrazzi, Eugenio Torre, Mitsuo Nishikawa, Maria Zingariello, Angela Di Baldassarre, Rosa Alba Rana, Rodolfo Lorenzini, Elena Alfani, Giovanni Migliaccio, Anna Rita Migliaccio
Journal: Blood
Blood (2005) 105 (9): 3493–3501.
https://doi.org/10.1182/blood-2004-04-1320
Published: 2005